Anjan Drug Private Limited - Company Profile

Q: Who are the current directors of Anjan Drug Private Limited?

The current directors of Anjan Drug Private Limited are Anil Khubchandani, Lakshay Kataria, Pagadala Baskarannarayanan, Vivek Chhachhi, Chinnannan Kalaichelvan, Santosh Kumar Mahil, Archana Jalla, Sumit Mohan Nadgir, Devi Thumati Krishnaraj.

It is a pharma private limited company based in Chengalpattu Dt, Tamil Nadu, India, established in 1990.

1990 Chengalpattu Dt, Tamil Nadu, India Active

Last Updated: December 17, 2025

Access Report

About Anjan Drug Private Limited

Anjan Drug Private Limited, a active private limited company, was established on 01 August 1990 in Chengalpattu Dt, Tamil Nadu, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231TN1990PTC019461. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹26.10 Cr and a paid-up capital of ₹5.88 Cr.

Formerly known as Anjan Drugs Private Limited. It upholds a compliant status. Employing 297 professional, Its leadership includes Anil Khubchandani (Director), Lakshay Kataria (Additional Director), Pagadala Baskarannarayanan (Director). Past directors included Divakar Madhusudan Gavaskar, Periyasamy Sivagnanam, Valliappan Venkatachalam. It holds ₹92.90 Cr open charges and ₹295.76 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.109 & 116,Sidcopharmaceutical I Estate,Alathur-603 110, Chengalpattu Dt, Tamil Nadu, 603110.

Company Details

CIN/LLPIN
U24231TN1990PTC019461
Registration Number
019461
Incorporation Date
01 August 1990
Authorized Capital
₹26.10 Cr
Paid-Up Capital
₹5.88 Cr
ROC Code
Roc Chennai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 26.10 Cr as on 17-12-2025
Paid Up Capital ₹ 5.88 Cr as on 17-12-2025
Company Age 35 Year, 7 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 92.90 Cr as on 17-12-2025
Satisfied Charges ₹ 295.76 Cr as on 17-12-2025
Revenue Growth **** 60.61% (FY 2023)
Profit Growth **** 123.00% (FY 2023)
Ebitda **** 112.52% (FY 2023)
Net Worth 35.42% (FY 2023)
Total Assets **** 26.95% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Anjan Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Anjan Drug Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Anil Khubchandani	Director	12 Oct 2023	Current
Lakshay Kataria	Additional Director	01 Apr 2025	Current
Pagadala Baskarannarayanan	Director	11 Jan 2023	Current
Vivek Chhachhi	Nominee Director	09 Oct 2020	Current
Chinnannan Kalaichelvan	Director	01 Aug 1990	Current
Santosh Kumar Mahil	Director	26 Jun 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	06 Aug 2018	Past
Pramod Abcsdd	Director	29 Feb 2016	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Additional Director	11 Oct 2023	Past
Pramod Abcsdd	Additional Director	26 Jun 2025	Past
Pramod Abcsdd	Additional Director	11 Oct 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anjan Drug.

Anjan Drug Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.61% increase. The company also saw a substantial improvement in profitability, with a 123% increase in profit. The company's net worth Soared by an impressive increase of 35.42%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

60.61%

*******

Revenue from Operations

*******

61.68%

*******

Total Assets

*******

26.95%

*******

Profit or Loss

*******

123.00%

*******

Net Worth

*******

35.42%

*******

EBITDA

*******

112.52%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anjan Drug?

In 2023, Anjan Drug had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹929,000,000.00

Satisfied Charges

₹2,957,563,600.00

Charges Breakdown by Lending Institutions

Axis Bank Limited : 31.70 Cr
Hdfc Bank Limited : 31.20 Cr
Others : 30.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
07 Mar 2022	Others	₹15.00 Cr	Open
21 Oct 2021	Hdfc Bank Limited	₹31.20 Cr	Open
01 Jun 2021	Others	₹15.00 Cr	Open
22 Apr 2021	Axis Bank Limited	₹31.70 Cr	Open
09 Jun 2022	Hdfc Bank Limited	₹14.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Anjan Drug?

Anjan Drug has a workforce of 297 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Anjan Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anjan Drug's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anjan Drug

Recent Activity within the Organization

Director Appointment

The activity Devi Thumati Krishnaraj was appointed as a Officer in default was appointed as a Officer in default on 16 Jul 2025 & has been associated with this company since 7 months 19 days . was completed.
16 Jul 2025
Director Appointment

Progress on Santosh Kumar Mahil was appointed as a Director was appointed as a Director on 26 Jun 2025 & has been associated with this company since 8 months 8 days . was documented.
26 Jun 2025
Director Appointment

The activity Sumit Mohan Nadgir was appointed as a Director was appointed as a Director on 01 May 2025 & has been associated with this company since 10 months 3 days . was completed.
01 May 2025
Director Appointment

Lakshay Kataria was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 11 months 3 days . was recorded as a recent event.
01 Apr 2025
Annual General Meeting

The activity Anjan Drug Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was completed.
30 Dec 2024
Balance Sheet

Progress on Anjan Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
31 Mar 2024

Explore recent activity and updates - View Recent Activity